These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16312526)

  • 1. Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment.
    Novelli A; Reali EF; Amato M; Dami A; Fallani S; Periti P
    J Chemother; 1989 Jul; 1(4 Suppl):546-8. PubMed ID: 16312526
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity.
    Thurmann-Nielsen E; Walstad RA; Dahl K; Hellum KB
    J Chemother; 1989 Jul; 1(4 Suppl):534-5. PubMed ID: 16312519
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioavailability and pharmacokinetics of enoxacin.
    Nakamura S; Kurobe N; Sekine Y
    J Chemother; 1989 Jul; 1(4 Suppl):543-4. PubMed ID: 16312524
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.
    Marchbanks CR; Mikolich DJ; Mayer KH; Zinner SH; Dudley MN
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1966-72. PubMed ID: 2291662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin.
    Misiak PM; Eldon MA; Toothaker RD; Sedman AJ
    J Clin Pharmacol; 1993 Jan; 33(1):53-6. PubMed ID: 8429114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the kinetics of tocainide in combined hepatic and renal insufficiency.
    Endell W; Oltmanns D; Pottage T
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):589-90. PubMed ID: 6420626
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacokinetics of cefixime in patients with renal insufficiency undergoing hemofiltration.
    König S; Marre R; Schulz E; Sack K
    J Chemother; 1989 Jul; 1(4 Suppl):536-7. PubMed ID: 16312520
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of enoxacin and its oxometabolite following intravenous administration to patients with different degrees of renal impairment.
    Van der Auwera P; Stolear JC; George B; Dudley MN
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1491-7. PubMed ID: 2221856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of newer antibiotics (enoxacin) in an in vitro placental perfusion model.
    Wachter I; Weissenbacher ER; Sorgel F; Nilius M; Metz R
    J Chemother; 1989 Jul; 1(4 Suppl):482. PubMed ID: 16312494
    [No Abstract]   [Full Text] [Related]  

  • 10. Elimination of enoxacin in renal disease.
    Bury RW; Becker GJ; Kincaid-Smith PS; Moulds RF; Whitworth JA
    Clin Pharmacol Ther; 1987 Apr; 41(4):434-8. PubMed ID: 3470166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin half-life in a patient with hepatic and renal dysfunction.
    Pachorek RE; Wood F
    Clin Pharm; 1991 Apr; 10(4):297-300. PubMed ID: 2032447
    [No Abstract]   [Full Text] [Related]  

  • 12. The absorption and disposition of enoxacin in healthy subjects.
    Somogyi AA; Bochner F
    J Clin Pharmacol; 1988 Aug; 28(8):707-13. PubMed ID: 3216037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers.
    Macgowan AP; Greig MA; Andrews JM; Reeves DS; Wise R
    J Chemother; 1989 Jul; 1(4 Suppl):593-6. PubMed ID: 16312548
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged digoxin elimination in two patients with renal and hepatic disease.
    Sorkness R
    Clin Pharm; 1983; 2(3):271-3. PubMed ID: 6883956
    [No Abstract]   [Full Text] [Related]  

  • 15. Calculation of dosage regimens of antimicrobial drugs in animals with renal and hepatic dysfunction.
    Riviere JE
    J Am Vet Med Assoc; 1984 Nov; 185(10):1094-7. PubMed ID: 6392236
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral enoxacin versus conventional intravenous antimicrobial therapy for chronic osteomyelitis.
    Jauregui LE; Hageage G; Martin M
    J Chemother; 1989 Jul; 1(4 Suppl):735-6. PubMed ID: 16312614
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
    Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of intravenous narcotics (barbiturates and fentanyl) anesthesia and intensive care in patients with liver and kidney insufficiency].
    Rietbrock I
    Klin Anasthesiol Intensivther; 1981; 23():59-70. PubMed ID: 7339178
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and clinical tolerability of FCE 22101, a new penem antibiotic, in healthy volunteers after a single i.m. administration.
    Hitzenberger G; Strolin Benedetti M; Jannuzzo MG; Silvestri S; Moro E; Frigerio E; Sassella D
    J Chemother; 1989 Jul; 1(4 Suppl):513-4. PubMed ID: 16312509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.